Arialys Therapeutics
Pharmaceutical Manufacturing
La Jolla, California, United States
20 employees
- Employees
- 20
- Contacts
- 2
- Emails
- 2
Arialys Therapeutics Overview
- Headquarters
- La Jolla, California, United States
- Industry
- Pharmaceutical Manufacturing
- Employees
- 20
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About Arialys Therapeutics
We now know that immune cells – not only in the body’s periphery but especially in the brain – can produce autoantibodies that cause severe neurological and psychiatric diseases. Founded to explore the latest discoveries in autoimmune neuropsychiatry, Arialys Therapeutics is developing new precision medicines to specifically block pathogenic autoantibodies in the brain and meaningfully expand the treatment possibilities for neuropsychiatric disorders driven by autoimmune disease.
Arialys Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
Arialys Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Mitsuyuki (Mickey) Matsumoto | Scientific Founder & Chief Scientific Officer at Arialys Therapeutics, Inc. |
View
|
|
| Mari Maurer, Bsn | Clinical Operations Executive | San Francisco Bay Area, United States |
Email
|
| Jay Lichter | Rancho Santa Fe, California, United States |
View
|
|
| Peter Flynn | President and CEO, Arialys Therapeutics | Cardiff-by-the-sea, California, United States |
Email
|
Employees by Management Level
Executive
2 profiles
Individual contributor
1 profile
Compare Similar Companies to Arialys Therapeutics
Neurocrine Biosciences
Biotechnology Research
Nimbus Therapeutics
Biotechnology Research
Artiva Biotherapeutics
Biotechnology Research
Apollo Therapeutics
Biotechnology Research
Enlaza Therapeutics
Biotechnology Research
Star Therapeutics
Biotechnology Research
Tentarix Biotherapeutics
Biotechnology
Actio Biosciences, Inc.
Biotechnology Research
Avalon BioVentures
Venture Capital And Private Equity Principals
Arrivo Bio
Biotechnology Research